Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and incb-018424

tenofovir has been researched along with incb-018424 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gavegnano, C; Haile, WB; Jiang, Y; Schinazi, RF; Tao, S; Tyor, WR1
Perricone, G; Pungolino, E; Vinci, M1

Other Studies

2 other study(ies) available for tenofovir and incb-018424

ArticleYear
The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.
    Neurobiology of disease, 2016, Volume: 92, Issue:Pt B

    Topics: Animals; Antiviral Agents; Astrocytes; Blood-Brain Barrier; Disease Models, Animal; Encephalitis, Viral; Gliosis; HIV Infections; HIV-1; Humans; Janus Kinase Inhibitors; Macrophages; Male; Mice; Monocytes; Nitriles; Pyrazoles; Pyrimidines; Tenofovir; Virus Replication

2016
Occult hepatitis B infection reactivation after ruxolitinib therapy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:6

    Topics: Aged; Antiviral Agents; Drug Resistance; Enzyme Inhibitors; Guanine; Hepatitis B, Chronic; Humans; Hydroxyurea; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Tenofovir; Virus Activation

2017